… -131 therapy is recommended for all differentiated thyroid cancer primary tumors >1cm in …
To treat metastastic differentiated thyroid cancer, higher activities of radio-iodine (in the range 4…

… of the American Thyroid Association (ATA) … thyroid cancers confined to the thyroid and high
risk features predicting an intermediate to high-risk of recurrence or death from thyroid cancer)…

… guidelines on the radioiodine therapy (RAIT) of differentiated thyroid cancer (DTC)
formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to …

… applicability of this treatment on the basis of personal experience. Thyroid carcinoma has an
… P Of the histologically differentiated tumors to which radioiodine therapy may be applicable, …

… diagnosis of papillary thyroid carcinoma, treated at MD Anderson Cancer Center, we identified
65 assessable patients in whom disease recurred after initial surgery and therapeutic RAI …

… In RAI therapy of differentiated thyroid carcinoma, several parameters are equally or
perhaps even more important than the administered activity in determining the radiation-absorbed …

… for ablation of residual thyroid tissue or for treatment of recurrent or metastatic cancer. The
… of the dose–response relationship on radioiodine therapy constitute the basis of this report. …

… radioiodine therapy over 30 years. In our experience, low dose radioiodine (<1.1 GBq) for
thyroid … 48-hour radioiodine retention in the neck was low (<2-3%) after thyroidectomy, and this …

… In the papillary carcinoma group with distant metastases, in eight patients less than 40 … , all
had metastases regress after radioiodine treatment. One later died of thyroid cancer. In the 17 …

… had occasion to use a treatment once or twice in … thyroid carcinoma, mainly with histologically
differentiated and inoperable tumours, for whom we have attempted radioiodine treatment …